Amoxirut-250 LB Capsule

Amoxicillin 250 mg + Lactobacillus 1.66 Billion Spores Capsules — Antibiotic + Probiotic

Amoxirut-250 LB Capsule — Amoxicillin 250 mg + Lactobacillus 1.66 Billion Spores from Trumac Healthcare PCD Pharma Franchise India

Composition Amoxicillin 250 mg + Lactobacillus 1.66 Billion Spores
Dosage Form Capsule
Pack Type Blister
Pack Size 10 x 10 Capsules
MRP ₹ 550
Therapy G.P. + Orthopaedics + Gynaecology + Dental + ENT — Aminopenicillin + Probiotic
Storage Store below 30 °C in a dry place, protected from light and moisture.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Amoxirut-250 LB Capsule

Amoxirut-250 LB Capsule pairs Amoxicillin 250 mg with Lactobacillus 1.66 Billion Spores — combining broad-spectrum antibiotic action with simultaneous probiotic protection of the gut microbiome. Antibiotic-associated diarrhoea (AAD) is one of the most common reasons for non-compliance with antibiotic therapy; co-administered probiotics significantly reduce its incidence.

Amoxicillin treats the underlying bacterial infection through cell-wall inhibition, while Lactobacillus replenishes beneficial gut flora that the antibiotic might otherwise disrupt. This combination is particularly valuable in paediatric practice and in adults with a history of antibiotic-associated diarrhoea.

Amoxirut-250 LB is manufactured by Trumac Healthcare under WHO-GMP conditions and is available for monopoly-based PCD pharma franchise and third-party manufacturing — a higher-margin antibiotic SKU with better patient compliance.

Indications

  • Bacterial infections requiring Amoxicillin with reduced AAD risk
  • ENT infections (otitis media, sinusitis, pharyngitis)
  • Lower respiratory tract infections
  • Dental and odontogenic infections
  • Uncomplicated UTIs
  • Skin and soft tissue infections in patients with history of antibiotic-related GI upset

Mechanism of Action

Amoxicillin inhibits bacterial cell wall synthesis by binding penicillin-binding proteins. Lactobacillus spores germinate in the intestine to produce lactic acid, which lowers gut pH, competes with pathogenic bacteria for adhesion sites and reduces growth of Clostridioides difficile — preventing antibiotic-associated dysbiosis and diarrhoea.

Dosage & Administration

Adults and children > 12 years: 1 capsule three times daily. Course typically 5–7 days, longer for severe infections. Take with water; the probiotic component is most active when taken 1–2 hours apart from antibiotic peak.

Side Effects

Mild GI upset, nausea, mild rash. Lower incidence of diarrhoea compared with plain Amoxicillin. Rare: hypersensitivity reactions, pseudomembranous colitis with prolonged use, anaphylaxis.

Contraindications & Precautions

Hypersensitivity to penicillins, cephalosporins or any beta-lactam. Infectious mononucleosis. Severe immunosuppression (caution with live probiotics). Severe acute pancreatitis. Renal impairment (dose adjustment).

Storage

Store below 30 °C in a dry place, protected from light and moisture.

PCD Pharma Franchise & Third-Party Manufacturing
Amoxirut-250 LB Capsule is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Amoxirut-250 LB Capsule used for?

Amoxirut-250 LB combines Amoxicillin 250 mg with Lactobacillus 1.66 Billion spores — used for bacterial infections while reducing the risk of antibiotic-associated diarrhoea.

Why is Lactobacillus added to Amoxicillin?

Lactobacillus protects beneficial gut flora that the antibiotic might otherwise disrupt, reducing the incidence of antibiotic-associated diarrhoea (AAD) and improving treatment compliance.

Is Amoxirut-250 LB available for PCD pharma franchise?

Yes, Trumac Healthcare offers Amoxirut-250 LB on monopoly-based PCD pharma franchise and for third-party manufacturing.

How should Amoxirut-250 LB Capsule be stored?

Store below 30 °C in a dry place, away from direct sunlight and moisture.

Is Amoxirut-250 LB WHO-GMP certified?

Yes, Amoxirut-250 LB Capsule is manufactured in WHO-GMP and DCGI-compliant facilities.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.